1.Research progress on mechanical thrombectomy for acute ischemic stroke beyond 24 hours of onset
Wanda SHI ; Xuesong BAI ; Wencheng KONG ; Liqun JIAO ; Yanxin ZHAO
Chinese Journal of Cerebrovascular Diseases 2024;21(5):349-354
Stroke is a major disease that endangers the health of human beings.Since 2015,mechanical thrombectomy has emerged as the primary therapeutic method for acute ischemic stroke.Present guidelines lean towards treating patients with mechanical thrombectomy within a therapeutic window,while the efficacy of thrombectomy beyond 24-hour remains a matter of contention.The authors manuscript undertook a retrospective review of extant clinical research,scrutinizing its safety and efficacy from the standpoint of research design,and offering a detailed synthesis concerning on predictive factors and imaging modalities for selection.
2.Research progress on screening and secondary prevention of atrial fibrillation in patients with ischemic stroke
Wencheng KONG ; Xuesong BAI ; Wanda SHI ; Liqun JIAO ; Yanxin ZHAO
Chinese Journal of Cerebrovascular Diseases 2024;21(6):412-418
Ischemic stroke is characterized by high rates of prevalence,mortality and recurrence.Atrial fibrillation(AF)is the most common arrhythmia in adults.AF significantly increases the risk of ischemic stroke and stroke recurrence.This review summarized the current research progress on AF screening in ischemic stroke patients,the relationship between AF characteristics,biomarkers and ischemic stroke,as well as the research progress on secondary prevention strategies for patients with concomitant AF,aiming to assist clinicians detect AF at an early stage and prevent stroke recurrence.